🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Phase 1 study to assess the safety, preliminary efficacy of CD19 t-haNK and...
Status
Withdrawn
Location
Chan Soon-Shiong Institute for Medicine
Start Date
2019-09-16
Trial ID
NCT04052061
Treatments Being Tested
Open-Label, Phase 2 Chemotherapy-Free Study ofCD19 t-haNK and NAI in Combin...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04
Trial ID
NCT07477366
Treatments Being Tested
Open Label, Phase 1 study of CD19 t-haNK as a single agent and combination ...
Status
Active Not Recruiting
Location
FARMOVS
Start Date
2024-08-23
Trial ID
NCT06334991
Treatments Being Tested
This is a phase 1, open-label study to evaluate the safety and efficacy of ...
Status
Terminated
Location
Dr Jackie Thomson Inc
Start Date
2025-04-11
Trial ID
NCT07556757
Treatments Being Tested
Open Label, Phase 2 Study of CD19 t-haNK and N-803 in Combination with Ritu...
Status
Recruiting
Location
Dr. Jackie Thomson Inc
Start Date
2025-11-11
Trial ID
NCT07125872
Treatments Being Tested
Open-label, Phase 1 Study of CD19 t-haNK as a Single Agent and in Combinati...
Status
Recruiting
Location
Hoag Memorial Hospital
Start Date
2025-08-22
Trial ID
NCT05618925
Treatments Being Tested